[go: up one dir, main page]

SI1280535T1 - - Google Patents

Info

Publication number
SI1280535T1
SI1280535T1 SI200030650T SI200030650T SI1280535T1 SI 1280535 T1 SI1280535 T1 SI 1280535T1 SI 200030650 T SI200030650 T SI 200030650T SI 200030650 T SI200030650 T SI 200030650T SI 1280535 T1 SI1280535 T1 SI 1280535T1
Authority
SI
Slovenia
Prior art keywords
clarithromycin
converting
processes
relates
present
Prior art date
Application number
SI200030650T
Other languages
English (en)
Inventor
Igor Lifshitz
Ilya Avrutov
Edi Schwartz
Basem Masarwa
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22640371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1280535(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of SI1280535T1 publication Critical patent/SI1280535T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI200030650T 2000-01-11 2000-12-15 SI1280535T1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17547700P 2000-01-11 2000-01-11
PCT/US2000/033844 WO2001051059A1 (fr) 2000-01-11 2000-12-15 Procedes de preparation de formes polymorphes de clarithromycine

Publications (1)

Publication Number Publication Date
SI1280535T1 true SI1280535T1 (fr) 2005-08-31

Family

ID=22640371

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030650T SI1280535T1 (fr) 2000-01-11 2000-12-15

Country Status (22)

Country Link
US (2) US6624292B2 (fr)
EP (1) EP1280535B1 (fr)
JP (1) JP2003519661A (fr)
KR (1) KR20020071012A (fr)
CN (1) CN1450903A (fr)
AT (1) ATE288758T1 (fr)
AU (2) AU2001222619C1 (fr)
BR (1) BR0016992A (fr)
CA (1) CA2397092A1 (fr)
DE (1) DE60018119T2 (fr)
DK (1) DK1280535T3 (fr)
ES (1) ES2236023T3 (fr)
HR (1) HRP20020572A2 (fr)
HU (1) HUP0204252A3 (fr)
IL (1) IL150698A0 (fr)
IS (1) IS6463A (fr)
PL (1) PL356645A1 (fr)
PT (1) PT1280535E (fr)
RU (1) RU2002118308A (fr)
SI (1) SI1280535T1 (fr)
WO (1) WO2001051059A1 (fr)
ZA (1) ZA200205229B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1666991A (zh) * 1999-12-16 2005-09-14 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法和新的多晶型物ⅳ
CN1450903A (zh) * 2000-01-11 2003-10-22 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
CA2401571A1 (fr) * 2000-02-29 2001-09-07 Ilya Avrutov Procedes de preparation de la clarithromycine et d'un intermediaire de la clarithromycine, notamment la clarithromycine exempte d'oxime, et composition pharmaceutique correspondante
AU6381201A (en) * 2000-03-28 2001-10-08 Biochemie Gmbh Granulated particles with masked taste
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
ES2288898T3 (es) * 2001-08-13 2008-02-01 Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione Uso de composiciones de claritromicina en la fabricacion de un medicamento para el tratamiento de la artritis deformante.
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005009368A2 (fr) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Produit antibiotique, utilisation et formulation correspondantes
EP1648415A4 (fr) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Produit antibiotique, son utilisation et sa formulation
CA2535177A1 (fr) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Pastille robuste
CA2535398C (fr) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotique, utilisation et formulation associees
WO2005023184A2 (fr) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Produit antibiotique, son utilisation et sa formulation
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005061524A2 (fr) * 2003-12-22 2005-07-07 Ranbaxy Laboratories Limited Procede pour la preparation de clarithromycine de forme ii
EP1701705A4 (fr) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Absorption amelioree de formes de dosage a liberation modifiee
WO2005072893A1 (fr) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Compositions metalliques colloidales fonctionnalisees
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP1771158A4 (fr) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Comprimé pour distribution par impulsion
CA2614412A1 (fr) * 2005-07-07 2007-01-18 Elan Pharma International, Limited Formulations de clarithromycine nanoparticulaires
US20070122483A1 (en) * 2005-11-29 2007-05-31 Sharon Myers Fluocinolone acetonide drug substance polymorphic interconversion
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2011026234A1 (fr) * 2009-09-02 2011-03-10 Bernard Charles Sherman Comprimé de clarithromycine à libération prolongée
AU2014348523B2 (en) 2013-11-15 2019-01-03 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4672056A (en) 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8721165D0 (en) 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5440505A (en) * 1994-01-21 1995-08-08 Intel Corporation Method and circuitry for storing discrete amounts of charge in a single memory element
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5756473A (en) 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5844105A (en) 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
CA2261732C (fr) * 1996-07-29 2001-07-24 Abbott Laboratories Preparation de la forme cristalline ii de la clarithromycine
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5852180A (en) 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US5892008A (en) 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100377159B1 (ko) 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
CN1666991A (zh) * 1999-12-16 2005-09-14 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法和新的多晶型物ⅳ
CN1450903A (zh) * 2000-01-11 2003-10-22 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法
CA2401571A1 (fr) 2000-02-29 2001-09-07 Ilya Avrutov Procedes de preparation de la clarithromycine et d'un intermediaire de la clarithromycine, notamment la clarithromycine exempte d'oxime, et composition pharmaceutique correspondante

Also Published As

Publication number Publication date
AU2261901A (en) 2001-07-24
HRP20020572A2 (en) 2005-04-30
PT1280535E (pt) 2005-04-29
DK1280535T3 (da) 2005-04-04
KR20020071012A (ko) 2002-09-11
RU2002118308A (ru) 2004-02-20
DE60018119D1 (de) 2005-03-17
EP1280535A1 (fr) 2003-02-05
CN1450903A (zh) 2003-10-22
EP1280535A4 (fr) 2003-02-05
WO2001051059A1 (fr) 2001-07-19
AU2001222619B8 (en) 2005-07-14
US6624292B2 (en) 2003-09-23
HUP0204252A3 (en) 2003-04-28
CA2397092A1 (fr) 2001-07-19
HUP0204252A2 (hu) 2003-03-28
AU2001222619C1 (en) 2006-01-12
IS6463A (is) 2002-07-09
PL356645A1 (en) 2004-06-28
EP1280535B1 (fr) 2005-02-09
ATE288758T1 (de) 2005-02-15
US20030216555A1 (en) 2003-11-20
AU2001222619B2 (en) 2005-04-28
ES2236023T3 (es) 2005-07-16
US20020028920A1 (en) 2002-03-07
ZA200205229B (en) 2003-06-30
BR0016992A (pt) 2002-12-31
DE60018119T2 (de) 2006-05-04
IL150698A0 (en) 2003-02-12
JP2003519661A (ja) 2003-06-24
US6987175B2 (en) 2006-01-17

Similar Documents

Publication Publication Date Title
SI1280535T1 (fr)
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
ZA200206253B (en) Oxygenate conversion process.
MXPA03005028A (es) Derivados de cetolida de 6-0-carbamoilo de eritromicina, utiles como antibacterianos.
MXPA03004761A (es) Turboalimentador sin alabes.
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
MXPA03004833A (es) SISTEMA REMOTO DE SEnALAMIENTO DE HUMEDAD.
MXPA03003573A (es) Factores de transcripcion de plantas.
AP2004003034A0 (en) Antibodies to CD40.
ZA200301673B (en) Cathartic composition.
MXPA02010485A (es) 1-aroil-piperidinil benzamidinas.
MXPA03002452A (es) Derivados de resorcinol.
MXPA03005268A (es) Sistema de sujecion de deslizamiento.
MXPA03003532A (es) Antibacterianos de cetolida.
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
MXPA03001504A (es) Seecion de linea de produccion.
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
ZA200107728B (en) Water distribution system.
AU2001288236A1 (en) Natural, non-allergenic, immune system stimulant
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
ES2197790A1 (es) Compuesto intermedio de utilidad en la sintesis de macrolidos.
YU53302A (sh) Postupci za pripremanje polimorfa klaritromicina
TW547434U (en) Wave-powered boat
MXPA04002104A (es) Anticuerpos contra caspasa-8, su preparacion y uso.
ZA200207575B (en) Hydrogen catalysis.